• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用社交媒体和法定医疗保险数据调查化脓性汗腺炎的诊断延迟。

Diagnostic delay in Hidradenitis suppurativa investigated using data from social media and from statutory health insurances.

机构信息

Haut- und Venenzentrum Mainz, Dr. med. Uwe Kirschner and Colleagues, Mainz, Germany.

Temedica GmbH, Munich, Germany.

出版信息

J Dtsch Dermatol Ges. 2024 Jun;22(6):803-809. doi: 10.1111/ddg.15411. Epub 2024 May 20.

DOI:10.1111/ddg.15411
PMID:38769083
Abstract

BACKGROUND

The chronic inflammatory skin disease hidradenitis suppurativa (HS) leads to severe pain and reduced quality of life. Nonetheless, it often takes years until a correct diagnosis is made. In this analysis, disease-related experiences and pathways of patients with HS were investigated and compared with the physicians' perspective.

METHODS

Public posts on forums and social media as well as results of a survey conducted among dermatologists and their patients on the actual medical care reality of HS in Germany were analysed. Furthermore, claims data from German health insurance companies were evaluated.

RESULTS

Patients with HS suffer from a 43.3% reduction in working ability. Dermatology (26.5%) was the most frequently consulted specialty, with HS diagnosed predominantly in the inpatient setting (43.8%). Abscesses were described as the most frequent alternative diagnosis in HS patients (53.2%). Patient-reported changes of physicians in dermatology (34.1%) and surgery (42.4%) occurred predominantly within the specialty. Dermatology received most referrals from general practitioners (67.1%), but only 12.1% from surgeons.

CONCLUSION

There is an urgent need to reduce the delay in diagnosis and the prolonged burden of disease in patients with HS. Therefore, awareness of the disease, its detection and treatment which goes beyond dermatology should be promoted, if possible as part of medical studies.

摘要

背景

慢性炎症性皮肤病化脓性汗腺炎(HS)会导致严重疼痛和生活质量下降。尽管如此,通常需要数年时间才能做出正确的诊断。在这项分析中,研究了 HS 患者的疾病相关经历和途径,并将其与医生的观点进行了比较。

方法

分析了论坛和社交媒体上的公开帖子,以及对德国皮肤科医生及其患者进行的关于 HS 实际医疗护理现状的调查结果。此外,还评估了德国健康保险公司的索赔数据。

结果

HS 患者的工作能力下降了 43.3%。皮肤科(26.5%)是最常咨询的专科,HS 主要在住院环境中诊断(43.8%)。脓肿被描述为 HS 患者最常见的替代诊断(53.2%)。报告称,皮肤科(34.1%)和外科(42.4%)的医生变化主要发生在专科内。皮肤科从全科医生(67.1%)获得的转诊最多,但只有 12.1%来自外科医生。

结论

迫切需要减少 HS 患者的诊断延迟和疾病负担的延长。因此,如果可能的话,应作为医学研究的一部分,提高对该病的认识,以及超越皮肤科的发现和治疗。

相似文献

1
Diagnostic delay in Hidradenitis suppurativa investigated using data from social media and from statutory health insurances.利用社交媒体和法定医疗保险数据调查化脓性汗腺炎的诊断延迟。
J Dtsch Dermatol Ges. 2024 Jun;22(6):803-809. doi: 10.1111/ddg.15411. Epub 2024 May 20.
2
Delayed Diagnosis of Hidradenitis Suppurativa and Its Effect on Patients and Healthcare System.化脓性汗腺炎的延误诊断及其对患者和医疗保健系统的影响。
Dermatology. 2020;236(5):421-430. doi: 10.1159/000508787. Epub 2020 Jul 1.
3
Treatment Satisfaction in Patients with Hidradenitis Suppurativa: A Real-World Survey from the EU5 and USA.化脓性汗腺炎患者的治疗满意度:来自欧盟五国和美国的一项真实世界调查
Dermatology. 2025;241(2):149-161. doi: 10.1159/000542343. Epub 2024 Nov 5.
4
Exploring racial and ethnic disparities in the hidradenitis suppurativa patient disease journey: Results from a real-world study in Europe and the USA.探究化脓性汗腺炎患者疾病历程中的种族和民族差异:欧洲和美国一项真实世界研究的结果
J Dermatol. 2024 Dec;51(12):1547-1558. doi: 10.1111/1346-8138.17386. Epub 2024 Oct 14.
5
Hidradenitis Suppurativa Patient Referrals to a Canadian Community Dermatology Practice: A Retrospective Chart Review.化脓性汗腺炎患者转诊至加拿大社区皮肤科诊所:一项回顾性图表研究。
J Cutan Med Surg. 2024 Mar-Apr;28(2):136-140. doi: 10.1177/12034754231223451. Epub 2024 Jan 19.
6
Validation of the real-world application of the Hidradenitis Suppurativa Quality of Life (HiSQOL) score to adults with hidradenitis suppurativa.化脓性汗腺炎生活质量(HiSQOL)评分在成年化脓性汗腺炎患者真实世界应用中的验证。
Br J Dermatol. 2025 Jan 24;192(2):261-268. doi: 10.1093/bjd/ljae367.
7
Clinical Characteristics of Hidradenitis Suppurativa Patients from a Reference Centre in Kaunas, Lithuania.立陶宛考纳斯参考中心的化脓性汗腺炎患者的临床特征。
Dermatology. 2020;236(1):66-70. doi: 10.1159/000505742. Epub 2020 Jan 15.
8
Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.皮肤科和性病科在莫斯塔尔临床医院用阿达木单抗治疗两例化脓性汗腺炎。
Acta Dermatovenerol Croat. 2021 Jul;29(2):108-110.
9
The patient journey: a voyage from diagnosis to hidradenitis suppurativa multidisciplinary unit.患者旅程:从诊断到化脓性汗腺炎多学科诊疗中心。
J Eur Acad Dermatol Venereol. 2019 Oct;33 Suppl 6:15-20. doi: 10.1111/jdv.15850.
10
Unmet clinical needs and burden of disease in hidradenitis suppurativa: real-world experience from EU5 and US.未满足的临床需求和疾病负担:来自欧盟 5 国和美国的真实世界经验。
J Eur Acad Dermatol Venereol. 2022 Sep;36(9):1597-1605. doi: 10.1111/jdv.18163. Epub 2022 May 9.